University of Texas Health Science Center at San Antonio-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Texas Health Science Center at San Antonio - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013590
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Texas Health Science Center at San Antonio (UTHSCSA), a subsidiary of University of Texas System is an educational university that offers undergraduate, graduate, and research programs to physicians, biomedical scientists, aging and longevity, cancer, cardiovascular, diabetes, infectious disease, military health, neuroscience, regenerative medicine and health-care professionals, among others. The center’s academic departments include school of medicine, dental school, school of health professions, and graduate school of biomedical sciences, school of nursing and affiliated colleges and schools. Its school of medicine provides courses in regions of cardiothoracic surgery, cellular and structural biology, epidemiology, biostatistics, anesthesiology, biochemistry, and other areas. UTHSCSA is headquartered in San Antonio, Texas, the US.

University of Texas Health Science Center at San Antonio – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Texas Health Science Center at San Antonio, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Texas Health Science Center at San Antonio, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Texas Health Science Center at San Antonio, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Texas Health Science Center at San Antonio, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Texas Health Science Center at San Antonio, Medical Devices Deals, 2011 to YTD 2017 9
University of Texas Health Science Center at San Antonio, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Texas Health Science Center at San Antonio, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
CSPC Pharma Enters into Licensing Agreement with University of Texas Health Science Center at San Antonio and University of Texas Health Science Center at Houston 11
CZ BioMed Entered Into Licensing Agreement With South Texas Technology Management For US Patent Related To RSV 12
Astrocyte Enters into Licensing Agreement with University of Texas Health Science Center 13
University of Texas Health Science Center at San Antonio – Key Competitors 14
University of Texas Health Science Center at San Antonio – Key Employees 15
University of Texas Health Science Center at San Antonio – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
University of Texas Health Science Center at San Antonio, Pharmaceuticals & Healthcare, Key Facts 2
University of Texas Health Science Center at San Antonio, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Texas Health Science Center at San Antonio, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Texas Health Science Center at San Antonio, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Texas Health Science Center at San Antonio, Deals By Therapy Area, 2011 to YTD 2017 8
University of Texas Health Science Center at San Antonio, Medical Devices Deals, 2011 to YTD 2017 9
University of Texas Health Science Center at San Antonio, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
CSPC Pharma Enters into Licensing Agreement with University of Texas Health Science Center at San Antonio and University of Texas Health Science Center at Houston 11
CZ BioMed Entered Into Licensing Agreement With South Texas Technology Management For US Patent Related To RSV 12
Astrocyte Enters into Licensing Agreement with University of Texas Health Science Center 13
University of Texas Health Science Center at San Antonio, Key Competitors 14
University of Texas Health Science Center at San Antonio, Key Employees 15

★海外企業調査レポート[University of Texas Health Science Center at San Antonio-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DBV Technologies SA (DBV):企業の財務・戦略的SWOT分析
    Summary DBV Technologies SA (DBV) is a biopharmaceutical company that develops products for the diagnosis and treatment of food and pediatric allergies. The company develops and markets non-invasive epicutaneous delivery technology and products for healthcare markets. Its viaskin technology platform …
  • Ego Pharmaceuticals Pty Ltd:企業の戦略的SWOT分析
    Ego Pharmaceuticals Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd:企業の戦略的SWOT分析
    The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employee …
  • Grupa Zywiec S.A.:企業の戦略・SWOT・財務情報
    Grupa Zywiec S.A. - Strategy, SWOT and Corporate Finance Report Summary Grupa Zywiec S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Accelya Solutions India Ltd (ACCELYA):企業の財務・戦略的SWOT分析
    Accelya Solutions India Ltd (ACCELYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Noble Energy Inc (NBL)-石油・ガス分野:企業M&A・提携分析
    Summary Noble Energy, Inc. (Noble Energy) is an independent energy company that explores for and produces crude oil, natural gas and natural gas liquids (NGLs). The company’s portfolio includes both US unconventional and global offshore conventional assets in various countries. Noble Energy has oper …
  • Green Cross Holdings Corp (005250):企業の財務・戦略的SWOT分析
    Summary Green Cross Holdings Corp (Green Cross) is a developer and manufacturer of pediatric and adult vaccines against infectious diseases. The company’s products comprise specialty medicines, general medicines, health functional foods, products for infants and toddlers, cosmetics, quasi drugs and …
  • Microbion Corp-製薬・医療分野:企業M&A・提携分析
    Summary Microbion Corp (Microbion) is a clinical stage biopharmaceutical company which develops therapeutic products. The company develops products for the treatment of antibiotic-resistant infections and control of microbial biofilms. It develops environmentally responsible solutions to prevent mic …
  • Petroleos de Venezuela SA:企業の戦略的SWOT分析
    Petroleos de Venezuela SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • GridEdge Networks Inc:企業の戦略的SWOT分析
    GridEdge Networks Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • ConvaTec Group Plc (CTEC):企業の財務・戦略的SWOT分析
    ConvaTec Group Plc (CTEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • University College London Hospitals NHS Foundation Trust:企業の戦略的SWOT分析
    University College London Hospitals NHS Foundation Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key …
  • China Haisheng Juice Holdings Co Ltd
    China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Euro India Fresh Foods, Ltd. (EIFFL):企業の財務・戦略的SWOT分析
    Euro India Fresh Foods, Ltd. (EIFFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Posco Daewoo Corporation (047050)-石油・ガス分野:企業M&A・提携分析
    Summary Posco Daewoo Corporation (Posco Daewoo), formally known as Daewoo International Corporation, is an international trading and investment company. It is involved in international trade, resource development and project organizing businesses. The company’s operational activities include export …
  • BEML Ltd:企業の戦略・SWOT・財務情報
    BEML Ltd - Strategy, SWOT and Corporate Finance Report Summary BEML Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • BTG Plc (BTG):製薬・医療:M&Aディール及び事業提携情報
    Summary BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for …
  • VA Tech Wabag Ltd (WABAG):企業の財務・戦略的SWOT分析
    Summary VA Tech Wabag Ltd (VA Tech) is engaged in the planning, design, installation and operation of water and wastewater plants. The company’s services include water treatment, desalination, waste water treatment, water reclamation, and sludge treatment. Its projects comprise Sundarijal Water Trea …
  • Ultra Petroleum Corp.:企業の戦略・SWOT・財務分析
    Ultra Petroleum Corp. - Strategy, SWOT and Corporate Finance Report Summary Ultra Petroleum Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Energy Resources of Australia Ltd (ERA):企業の財務・戦略的SWOT分析
    Energy Resources of Australia Ltd (ERA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆